← Back

Guangdong Hongteo Accurate Technology Co Ltd

GuangDong HongTeo Technology Co.,Ltd. engages in the design, manufacturing, processing, and sale of aluminum alloy precision die castings, auto parts, key parts and components of automotive dual clutch transmission (DCT), and communication parts in China and internationally. The company offers battery tray assembly, electrical control box housing, battery box front panel, rear panel of battery box, gearbox housing, electrical control box housing, casing, motor housing inner shell, motor housing inner shell, and PIM housing. It also provides flywheel housing, trapezoidal frame plate, timing gear housing, high-pressure die-cast pipe bend, nano2020 ladder frame, oil pan, lower cylinder, head and oil filter cooler, camshaft housing assembly, and oil filter cooling housing. In addition, the company is involved in the provision of financial technology and environmental protection services, as well as industrial investment activities. The company was formerly known as Guangdong Paisheng Intelligent Technology Co.,Ltd and changed its name to GuangDong HongTeo Technology Co.,Ltd. in November 2024. GuangDong HongTeo Technology Co.,Ltd. was founded in 2003 and is based in Zhaoqing, China.

Price · split & dividend adjusted
News & notes moving 300176.CS
300176.CS2

Hongte Technology Implements Rights Issue, Trading Suspended from August 13

Hongte Technology announced that the company is implementing a rights issue, planning to allot A shares to all shareholders registered after market close on the record date of August 12, 2026, at a ratio of 4 rights shares for every 10 shares held. According to relevant regulations, August 13 to August 19, 2026 is the payment period for the rights issue, during which the company's shares will be suspended from trading all day; August 20 is the online clearing period, with trading suspended for one more day; trading will resume when the market opens on August 21.
CLS·14dRead more ▾
300176.CS3

Hongte Technology Launches Rights Issue via Agency Sales

Hongte Technology announced that the company has launched a rights issue via agency sales, based on a total share capital of 387 million shares, offering 4 rights shares for every 10 existing shares to all shareholders, with a total of 155 million shares available for subscription. The rights issue is expected to raise no more than 650 million yuan, which will be used for the construction of an auto parts production base in Thailand, technical upgrades at the Zhaoqing production base, construction of the headquarters R&D center, and replenishment of working capital.
CLS·14dRead more ▾
300176.CS

Talkweb Information System First-Half Net Profit Falls 12.16% Year-on-Year

Talkweb Information System released its 2026 semi-annual report, achieving operating revenue of 1.312 billion yuan, up 0.39% year-on-year, with net profit attributable to shareholders of the listed company at 69.222 million yuan, down 12.16% year-on-year. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders. As of the end of the reporting period, the company had over 30 products certified through OpenHarmony compatibility assessment, with related products in the market expansion and application stage. In other news, WuXi AppTec announced that a U.S. court has granted its preliminary injunction motion, shielding the company from immediate adverse impact while it challenges the U.S. Department of Defense's 1260H designation in judicial proceedings. Gaozheng Explosives' controlling shareholder is set to change to Tibet Geology and Mineral Resources Group. Ningxia Building Materials plans to repurchase shares worth 100 million to 200 million yuan for cancellation. Wuhan P&S Information Technology saw semi-annual net profit surge 209.5% year-on-year. Galaxy Microelectronics' semi-annual net profit rose 77.28% year-on-year. Hongte Technology plans to raise no more than 650 million yuan through a rights issue for its Thailand base and other projects. Tuoxin Pharmaceutical plans to raise no more than 228 million yuan through a private placement of shares. Biolight has terminated the planned change of control, and its shares and convertible bonds will resume trading on August 10. Huadong Medicine's wholly-owned subsidiary obtained EU MDR CE certification for its medical aesthetics product. Jumpcan Pharmaceutical's subsidiary obtained drug registration certificates for pediatric laxative granules and mesalazine sustained-release granules. Chinese Health's wholly-owned subsidiary had its drug registration application for ferrous succinate tablets accepted.
CLS·17dRead more ▾